Chargepoint Holdings Inc SEC Filings

ChargePoint Holdings insider John David Vice, the company's Chief Risk Officer, reported a transaction on 09/23/2025 selling 2,363 shares of common stock at $11.2714 per share. The Form 4 explains these shares were sold to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units under the company’s equity plans, described as a mandatory ‘‘sell to cover’’ rather than a discretionary trade. After the sale (and adjusted for a 1-for-20 reverse stock split effective 07/28/2025), the reporting person beneficially owns 123,615 shares. The filing was signed by an attorney-in-fact on 09/24/2025.

Jagdeep Singh, an officer (CCXO) of ChargePoint Holdings, Inc. (CHPT), reported a non-discretionary sale of common stock to satisfy tax withholding obligations. The Form 4 shows a sale of 1,703 shares on 09/23/2025 at a price of $11.2714 per share, leaving the reporting person with 129,459 shares beneficially owned after the transaction. The filing notes a 1-for-20 reverse stock split effective 07/28/2025 and that the reported totals reflect that adjustment. It also discloses acquisition of 500 shares via the Employee Stock Purchase Plan on 09/09/2025, which was exempt under Rule 16b-3. The sale was a mandated "sell to cover" tied to restricted stock unit vesting and not a discretionary trade.

ChargePoint Holdings insider filing: CFO Mansi Khetani reported a sale of 1,302 shares of ChargePoint common stock on 09/23/2025 at a price of $11.2714 per share. The filing states the sale was a mandatory "sell-to-cover" to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units and was not a discretionary trade. After the reported transaction, the reporting person beneficially owned 134,306 shares (amounts adjusted for the 1-for-20 reverse stock split effective July 28, 2025). The filing also notes acquisition of 500 shares under the Employee Stock Purchase Plan on 09/09/2025.

Wilmer Richard, President, CEO and director of ChargePoint Holdings, Inc. (CHPT), reported a non-sale transaction dated 09/20/2025 where 2,774 shares of common stock were withheld by the issuer at a price of $10.85 to satisfy tax withholding obligations related to vested restricted stock units. Following the transaction, Mr. Richard beneficially owned 494,143 shares. The filing notes a 1-for-20 reverse stock split effective July 28, 2025, and that the reported total includes 500 shares acquired under the Employee Stock Purchase Plan on September 9, 2025.

ChargePoint Holdings, Inc. (CHPT) filing a Form 144 notifies the intended sale of 2,363 shares of common stock on the NYSE with an aggregate market value of $26,634.42. The shares to be sold represent approximately 0.0101% of the 23,353,260 shares outstanding, indicating a very small proposed sale relative to the company's total shares. The securities were acquired on 09/20/2025 as the settlement of vested restricted stock units issued under an S-8 registered plan; the filer acquired 9,688 shares in that settlement and intends to sell part of them on or about 09/23/2025. The filing states there were no securities sold in the past three months by the person for whose account the sale is proposed.

ChargePoint Holdings, Inc. (CHPT) filed a Form 144 disclosing a proposed sale of 1,703 shares of common stock on 09/23/2025 on the NYSE with an aggregate market value of $19,195.27. The shares were acquired on 09/20/2025 through settlement of vested restricted stock units issued under an S-8 registered plan; the filer received 4,742 shares in that settlement and the payment was recorded as equity compensation for services rendered on 09/20/2025. The Form 144 reports 23,353,260 shares outstanding. The filer reports nothing to report for securities sold in the past three months. Several issuer and filer identification fields in the filing are blank in the provided content.

ChargePoint Holdings, Inc. (CHPT) filed a Form 144 reporting a proposed sale of 1,302 shares of common stock on the NYSE through E*TRADE with an aggregate market value of $14,675.42, with an approximate sale date of 09/23/2025. The filing lists total shares outstanding of 23,353,260.

The filer states the shares were acquired on 09/20/2025 as settlement of 3,623 vested RSUs issued under an S-8 registered plan, paid as equity compensation. The form indicates no securities were sold by the filer in the past three months and includes the standard signer representation about material nonpublic information.

Form 144 notice for ChargePoint Holdings, Inc. (CHPT) states an intended sale of 2,058 shares of common stock on 09/23/2025 through ETRADE at an aggregate market value of $23,196.63. The filing reports 23,353,260 shares outstanding. The shares to be sold were acquired on 09/20/2025 as the settlement of vested RSUs issued under an S-8 registered plan; the acquisition record shows 5,725 shares and payment characterized as equity compensation for services rendered. No securities of the issuer were reported sold by the holder in the past three months. Several standard filer and issuer contact fields and the filers relationship to the issuer are not provided in the visible content.

ChargePoint Holdings, Inc. (CHPT) files a shelf registration (Form S-3) prospectus describing available securities and the terms under which debt or equity may be offered. The company notes its common stock is listed on the NYSE under the symbol CHPT and Continental Stock Transfer & Trust Company serves as transfer agent. As of July 31, 2025, there were 23,357,878 shares of common stock outstanding and no preferred shares outstanding. The filing discloses stock-based instruments outstanding: 121,133 option shares (weighted-average exercise $15.46), 3,454,584 RSU shares, reserved shares for the 2021 Plan and ESPP, 1,724,971 shares issuable on Legacy Warrants (WA $144.29), and 1,358,507 shares issuable on Convertible Notes. An illustrative Sales Agreement example assumes sale of 13,914,656 shares at $10.78/share for $150,000,000 gross proceeds and shows pro forma net tangible book value and dilution sensitivities to $1 changes in price. The prospectus incorporates specified SEC-filed reports by reference and lists forward-looking risks including market adoption, product delays, incentives, competition, data security, and potential internal control weaknesses. The document explains governance provisions: a classified board, advance notice bylaws, restrictions on stockholder action by written consent, ability of the Board to issue undesignated preferred stock, Delaware Section 203 protections, and exclusive forum selection for many internal claims.